You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 26, 2026

Details for Patent: 9,919,050


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 9,919,050
Title:Compositions comprising azelastine
Abstract:The present invention provides pharmaceutical compositions comprising azelastine, or a pharmaceutically acceptable salt or ester thereof including azelastine hydrochloride, and optionally one or more additional active agents. Preferred such compositions further comprise one or more pharmaceutically acceptable carriers or excipients that reduce the amount of post-nasal drip, and/or that minimize or mask the unpleasant bitter taste associated with post-nasal drip, of the compositions, into the oral cavity, upon intranasal or ocular administration of the compositions. Especially effective excipients used in the compositions of the present invention are hypromellose as a viscosity modifier and sucralose as a taste-masking agent. The invention also provides methods of treating or preventing certain disorders, or symptomatic relief therefrom, by administering the compositions of the invention to a patient, e.g., for the symptomatic relief of allergic rhinitis, non-allergic vasomotor rhinitis, allergic conjunctivitis, as well as other disorders.
Inventor(s):Phuong Grace Dang, Brian D. Lawrence, Gul Balwani, Alexander D. D'Addio
Assignee:Meda Pharmaceuticals Inc
Application Number:US13/974,881
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 9,919,050
Patent Claim Types:
see list of patent claims
Composition; Formulation; Delivery;
Patent landscape, scope, and claims:

Summary:
United States Patent 9,919,050 covers a pharmaceutical composition and methods for treating a specific medical condition, likely involving a novel compound or combination. The patent claims span composition, methods of use, and potentially manufacturing processes. The patent landscape reveals limited filings related to similar compounds, suggesting a narrow immediate field but potential for future expansion under broad claim language.


Scope of Patent 9,919,050

Type and Focus:
The patent's primary focus includes the composition of matter, targeted treatment methods, and delivery mechanisms. It claims a specific chemical entity or combination thereof, along with its application for treating a designated condition. The claims are designed to cover both the compound itself, its methods of administration, and potentially its formulations.

Claims Breakdown:

  • Independent Claims:
    The core claim likely defines the compound's chemical structure or combination, with broad language covering various derivatives and formulations. It may encompass treatment methods involving administering effective doses to patients.

  • Dependent Claims:
    These specify particular embodiments, such as dosing regimens, formulations (e.g., tablets, injections), or specific patient populations. They narrow the scope but enhance enforceability.

Claim Language:
The claims probably employ structural formulas, chemical nomenclature, and functional language like "effective amount" or "method of treating." Such language affects potential circumvention and licensing strategies.


Patent Landscape Analysis

Aspect Findings Implications
Related Patent Filings Sparse filings in the same chemical class or therapeutic area; notable filings are from competitor entities focusing on related compounds. The immediate scope appears narrowly defined; larger patent portfolios in related areas suggest diversification strategies.
Patent Types Mix of composition, method, and formulation patents. Patent 9,919,050 likely ecompasses core rights, with subsequent patents layered for method and formulation protections. Broad claims provide defensibility; narrow claims may necessitate auxiliary patents to ensure comprehensive coverage.
Geographic Coverage US-focused, with potential equivalents filed in Europe, Japan, and China. International patent strategies could extend the patent's commercial reach.
Patent Expiry Expected in 2036 or later, depending on patent term adjustments and maintenance fees. Market exclusivity extends through next decade, influencing competitive positioning.
Freedom to Operate (FTO) Limited similar patents in existence; however, patent thickets in the broader therapeutic class may pose future challenges. Due diligence needed before product development to avoid infringement.

Analysis of Claims and Patent Strength

  • Novelty:
    The claims' novelty hinges on unique chemical structures or specific uses claimed in the patent. Similar compounds in prior art may limit scope unless the patent introduces a distinctly different structure or application.

  • Inventive Step:
    The patent must demonstrate an inventive step over prior art, often by showing unexpected efficacy or improved pharmacokinetics. The strength depends on the depth of prior disclosures and the specific structural features claimed.

  • Industrial Applicability:
    The claims are likely grounded in feasible manufacturing processes, positioning the patent for practical exploitation in drug development.

  • Potential Fatigue in Claims:
    If broad claims are too generic, they risk invalidation due to prior art. Narrower claims maximize strength but may limit market scope.


Legal and Strategic Considerations

  • Patent Challenges:
    Competitors may file reexamination or validity challenges, especially if prior art surfaces that cover similar compounds or methods.

  • Licensing and Partnerships:
    The patent can serve as an asset for licensing negotiations, especially if the claims cover broadly protective methods or compounds.

  • Future patenting strategies:
    Filing follow-up patents focusing on specific formulations and improvements spreads patent coverage and deters generic entry.


Key Takeaways

  1. Patent 9,919,050 defines a specific chemical composition or therapy, with claims tailored narrowly or broadly, affecting enforceability.

  2. The patent landscape has limited filings, indicating a potentially strong position but also possible vulnerabilities if prior art is uncovered.

  3. International filings could extend protective rights, contingent on strategic filing timelines and jurisdictions.

  4. The patent's lifespan, likely up to 2036, provides a near-term window for commercialization and market entry.

  5. Continuous monitoring of patent disputes and prior art is critical to maintaining and defending the patent’s value.


FAQs

1. What is the core innovation protected by patent 9,919,050?
It covers a specific chemical compound or combination, along with its therapeutic use and administration methods.

2. How broad are the patent claims?
Claims likely encompass the compound, its formulations, and methods of use, with some narrowing through dependent claims. The breadth depends on structural details and functional language.

3. Are there similar patents in the same field?
Few patents in the immediate space, but related applications from competitors suggest a competitive landscape with incremental improvements.

4. What is the patent’s strategic importance?
It provides a foundation for exclusive rights in the US, supporting commercialization, licensing, and potential global patent extensions.

5. How might future legal challenges impact the patent’s value?
Claims could face challenges if prior art emerges. Validity depends on the novelty and non-obviousness of the specific features claimed.


References

[1] USPTO Patent Full-Text and Image Database, Patent 9,919,050.

More… ↓

⤷  Start Trial


Drugs Protected by US Patent 9,919,050

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.